DE
Kontakt
TeamExpertise
NewsRankings & AwardsPublikationen
Über unsKarriereKontakt
de|fr|it|en
FRITEN
Kontakt
TeamExpertise
NewsRankings & AwardsPublikationen
Über unsKarriereKontakt
de|fr|it|en
FRITEN
de|fr|it|en
Basel Bern Binningen China Desk Genf Gstaad Japan Desk Lausanne Lugano Sion ZürichBasel Bern Binningen China Desk Genf Gstaad Japan Desk Lausanne Lugano Sion Zürich
  • Team
  • Expertise
  • News
  • Rankings & Awards
  • Publikationen
  • Über uns
  • Karriere
  • Kontakt
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026
  • Team
  • Expertise
  • News
  • Rankings & Awards
  • Publikationen
  • Über uns
  • Karriere
  • Kontakt
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026

Deals & Cases

Dr. Eliane Haas
  • Kellerhals Carrard with Seprify on Series A round and collaboration with Oterra Kellerhals Carrard with Seprify on Series A round and collaboration with Oterra 12. März 2026
  • Kellerhals Carrard advises Vsquared Ventures on AlphaLum’s CHF 3.4 Million Seed Financing RoundKellerhals Carrard advises Vsquared Ventures on AlphaLum’s CHF 3.4 Million Seed Financing Round20. Januar 2026
  • Deal Ticker: Kellerhals Carrard supports Galenica to enter the diagnostics business by acquiring Labor TeamDeal Ticker: Kellerhals Carrard supports Galenica to enter the diagnostics business by acquiring Labor Team3. Juli 2025
  • Deal Ticker: Kellerhals Carrard advises TecMed on the Acquisition of Ypsomed Diabetes Care to Build Global Insulin PowerhouseDeal Ticker: Kellerhals Carrard advises TecMed on the Acquisition of Ypsomed Diabetes Care to Build Global Insulin Powerhouse22. April 2025
  • Deal Ticker: Kellerhals Carrard berät Orell Füssli bei der Übernahme der Verlag SKV AGDeal Ticker: Kellerhals Carrard berät Orell Füssli bei der Übernahme der Verlag SKV AG13. März 2025
  • Deal Ticker: Kellerhals Carrard advises Ego Death Capital on $12M Series A Funding Round for Relai Deal Ticker: Kellerhals Carrard advises Ego Death Capital on $12M Series A Funding Round for Relai 13. Dezember 2024
  • Deal Ticker: Kellerhals Carrard advises Panakes Partners in the EUR 17.9 million Series B Financing Round of Lymphatica MedtechDeal Ticker: Kellerhals Carrard advises Panakes Partners in the EUR 17.9 million Series B Financing Round of Lymphatica Medtech16. Oktober 2024
  • Orrick and Kellerhals Carrard for Partech in the Series C of xFarmOrrick and Kellerhals Carrard for Partech in the Series C of xFarm15. Oktober 2024
  • Deal Ticker: Kellerhals Carrard Advises Rhenopharma Group in Acquisition of Konapharma AGDeal Ticker: Kellerhals Carrard Advises Rhenopharma Group in Acquisition of Konapharma AG28. Juni 2024
  • Deal Ticker: Kellerhals Carrard Advises WellDev AG on Acquisition of InnoTix AGDeal Ticker: Kellerhals Carrard Advises WellDev AG on Acquisition of InnoTix AG7. März 2024
  • Deal Ticker: Kellerhals Carrard advised palero on the acquisition of Fischer Söhne AGDeal Ticker: Kellerhals Carrard advised palero on the acquisition of Fischer Söhne AG9. August 2023
  • Orell Füssli übernimmt die Mehrheit am hep VerlagOrell Füssli übernimmt die Mehrheit am hep Verlag8. Juli 2022